[Association between vitamin D receptor gene polymorphisms and pediatric Crohn's disease in China: a study based on

You-You Luo1, Xiao-Li Shu, Hong Zhao

  • 1Department of Gastroenterology, Children's Hospital of Zhejiang University, School of Medicine, Hangzhou 310003, China. hzcjie@zju.edu.cn.

Insights

Pediatric Crohn's disease (CD) patients in China exhibit lower serum vitamin D levels. However, specific vitamin D receptor (VDR) gene polymorphisms (TaqI, BsmI, ApaI) do not appear to be associated with CD susceptibility in this population.

Area of Science:

  • Genetics
  • Immunology
  • Pediatrics

Context:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease affecting children.
  • Vitamin D deficiency is common in CD patients.
  • Vitamin D receptor (VDR) gene polymorphisms may influence disease susceptibility.

Purpose:

  • To examine the relationship between VDR gene polymorphisms (TaqI, BsmI, ApaI) and pediatric CD in China.
  • To compare serum 25-hydroxyvitamin D3 [25(OH)D3] levels between pediatric CD patients and healthy controls.

Summary:

  • This study analyzed 19 pediatric CD cases and 122 healthy controls in China.
  • Serum 25(OH)D3 levels were significantly lower in children with CD compared to controls.
  • No significant differences were found in the genotype or allele frequencies of VDR gene polymorphisms (TaqI, BsmI, ApaI) between the groups.

Impact:

  • Findings suggest that low serum vitamin D levels are associated with pediatric CD in China.
  • The studied VDR gene polymorphisms may not be a significant genetic factor for CD susceptibility in the Chinese pediatric population.
  • Further research is needed to explore other genetic and environmental factors contributing to pediatric CD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.1K